She was 67, a grandmother, diagnosed with Stage IV ER/PR-positive, HER2-negative breast cancer — with metastases through her bones. Standard chemotherapy left her devastated: fatigue, nausea, hair loss, neuropathy, and no lasting results. She vowed never again.

In this episode of Outsmart Cancer, Dr. Dino Prato, founder of Envita Medical Centers, shares how precision oncology changed everything. Using deep mapping (DNA, RNA, immune, and spatial biology), his team discovered blocked immune pathways and stromal barriers — the “walls” preventing chemo and immune cells from reaching the cancer.

Through genetically targeted fractionated chemotherapy (GTF), image-guided interventional oncology, and immune retraining with NK and dendritic cells, this grandmother achieved what she wanted most — real healing without the suffering. In 14 weeks, bone pain was gone, energy returned, and her life reignited.

🎯 What You’ll Learn in This Episode:
• Why HER2-negative, hormone-resistant breast cancers are harder to treat
• How deep DNA/RNA mapping finds hidden resistance pathways
• What stromal barriers are — and how to break them
• How microdosed chemo and direct tumor delivery reduce toxicity
• Why immune retraining helps achieve lasting remission
• The six essential questions every cancer patient should ask their doctor

📍 Envita Medical Centers – Scottsdale, AZ
🌐 Learn more: www.envita.com
📞 Speak to a care coordinator: 866-830-4576

“This wasn’t luck — it was precision. And precision changes everything.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

https://www.scirp.org/journal/paperinformation?paperid=132493